Multisystem impairment in South African adolescents with Perinatally acquired HIV on antiretroviral therapy (ART).

Journal: Journal of the International AIDS Society

Volume: 22

Issue: 8

Year of Publication: 2020

Affiliated Institutions:  Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa. Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa. Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa. Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.

Abstract summary 

Adolescents with perinatally acquired HIV (PHIV) are at risk of chronic disease due to long-standing immune suppression, HIV disease and antiretroviral therapy (ART) exposure. However, there are few data on multisystem disease in this population. We investigated the overlapping burden of neurocognitive, cardiovascular, respiratory and/or renal impairment among PHIV positive (PHIV+) adolescents.In this cross-sectional analysis, participants aged 9 to 14 years on ART for >6 months were recruited from seven sites across Cape Town from July 2013 through March 2015, together with age-matched HIV-negative (HIV-) adolescents. Impairment at enrolment was assessed across neurocognitive functioning (using the youth-International HIV Dementia Scale); cardiac function (echocardiogram abnormality); respiratory function (abnormal spirometry) and renal function (abnormal glomerular filtration rate).Overall, 384 PHIV+ and 95 HIV- adolescents were included (mean age, 11.9 years; 49% female). Median age of ART initiation was 4.2 years (IQR: 1.7 to 7.6) and median CD4 count was 709 (IQR: 556 to 944) with 302 (79%) of PHIV+ adolescents virologically suppressed. Abacavir and Zidovudine were the most commonly used nucleoside reverse transcriptase inhibitors (NRTIs) with 60% of adolescents on non-nucleoside reverse transcriptase inhibitors (NNRTI) and 38% on a protease inhibitor (PI). Among PHIV+ adolescents, 167 (43.5%) had single system impairment only, 110 (28.6%) had two systems involved, and 39 (10.2%) had three or four systems involved. PHIV+ participants had more 2-system and 3-system impairment than HIV-, 110 (28.6%) versus 17 (17.9%), p = 0.03 and 39 (10.2%) versus 3 (4.3%), p = 0.03. PHIV+ participants who had failed a year of school (73.8% vs. 46.4%, p = 0.00) and with a viral load >1000 copies/mL at enrolment (16.8% vs. 8.1%, p = 0.03) were more likely to have dual or multisystem impairment. Of those with cardiac impairment, 86.7% had an additional system impaired. Similarly, in those with neurocognitive impairment, almost 60% had additional systems impaired and of those with respiratory impairment, 74% had additional systems impaired.Despite relatively early ART initiation, there is a substantial burden of multisystem chronic impairment among PHIV+ adolescents. This phenomenon needs to be further explored as this population ages and begins to engage in adult lifestyle factors that may compound these impairments.

Authors & Co-authors:  Frigati Lisa J LJ Brown Karryn K Mahtab Sana S Githinji Leah L Gray Diane D Zühlke Liesl L Nourse Peter P Stein Dan J DJ Hoare Jaqueline J Cotton Mark F MF Myer Landon L Zar Heather J HJ

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Slogrove AL, Sohn AH. The global epidemiology of adolescents living with HIV: time for more granular data to improve adolescent health outcomes. Curr Opin HIV AIDS. 2018;13(3):170–8.
Authors :  12
Identifiers
Doi : e25386
SSN : 1758-2652
Study Population
Male,Female
Mesh Terms
Adolescent
Other Terms
Sub-Saharan Africa;antiretroviral therapy;chronic disease;multisystem morbidity;perinatally HIV-positive adolescents
Study Design
Cross Sectional Study
Study Approach
Country of Study
Mali
Publication Country
Switzerland